TWO SIGMA INVESTMENTS, LP - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$39,234,000
+11.3%
461,415
-53.6%
0.14%
-20.6%
Q2 2020$35,248,000
+14170.4%
994,594
+5334.9%
0.18%
+8650.0%
Q1 2020$247,000
-87.4%
18,300
-80.3%
0.00%
-66.7%
Q4 2019$1,966,000
+680.2%
92,926
+668.0%
0.01%
+500.0%
Q3 2018$252,000
-30.6%
12,100
-21.2%
0.00%0.0%
Q2 2018$363,000
-96.1%
15,348
-97.7%
0.00%
-97.0%
Q3 2017$9,255,000
+113.9%
662,014
+35.1%
0.03%
+106.2%
Q2 2017$4,326,000
+232.5%
489,887
+143.6%
0.02%
+300.0%
Q1 2017$1,301,000
+468.1%
201,100
+222.8%
0.00%
+300.0%
Q4 2016$229,000
+16.2%
62,300
+52.0%
0.00%0.0%
Q4 2014$197,00040,9750.00%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 10,488,076$92,610,00011.69%
First Light Asset Management, LLC 2,048,643$18,090,0006.07%
Foresite Capital Management III, LLC 1,940,850$17,138,0005.60%
DAFNA Capital Management LLC 637,700$5,631,0004.02%
ACUTA CAPITAL PARTNERS, LLC 1,600,000$14,128,0003.95%
Opaleye Management Inc. 900,000$7,947,0003.32%
Ghost Tree Capital, LLC 1,200,000$10,596,0002.20%
Iguana Healthcare Management, LLC 325,000$2,870,0001.62%
Healthcare Value Capital, LLC 100,000$883,0001.59%
Palo Alto Investors LP 3,010,466$26,582,0001.24%
View complete list of IMMUNOMEDICS INC shareholders